Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Cohen

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Brain Imaging and Behavior|January 26, 2011
Subcortical brain atrophy persists even in HAART-regulated HIV diseaseJames T Becker, Joanne Sanders, Sarah K Madsen, et al.
Archives of Neurology|January 11, 2007
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infectionJeffrey J Sevigny, Steven M Albert, Michael P McDermott, et al.
The Lancet. Neurology|February 3, 2009
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II studyRichard K Burt, Yvonne Loh, Bruce Cohen, et al.
Nature Communications|July 18, 2023
An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease modelsWoori Kim, Mohit Tripathi, Chunhyung Kim, et al.
The Journal of General Physiology|February 6, 2019
Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensorsAmol V Shivange, Philip M Borden, Anand K Muthusamy, et al.
Pediatric Blood & Cancer|April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Journal of Neurology|May 16, 2009
Factors that influence adherence with disease-modifying therapy in MSKatherine Treadaway, Gary Cutter, Amber Salter, et al.
Journal of Athletic Training|May 2, 2023
Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus StatementJeffrey B Driban, Heather K Vincent, Thomas H Trojian, et al.
Journal of Athletic Training|May 2, 2023
Evidence Review for Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus Statement, Jeffrey B Driban, Heather K Vincent, et al.
Orphanet Journal of Rare Diseases|November 22, 2024
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trialAmel Karaa, Enrico Bertini, Valerio Carelli, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Brain Imaging and Behavior|January 26, 2011
Subcortical brain atrophy persists even in HAART-regulated HIV diseaseJames T Becker, Joanne Sanders, Sarah K Madsen, et al.
Archives of Neurology|January 11, 2007
An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infectionJeffrey J Sevigny, Steven M Albert, Michael P McDermott, et al.
The Lancet. Neurology|February 3, 2009
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II studyRichard K Burt, Yvonne Loh, Bruce Cohen, et al.
Nature Communications|July 18, 2023
An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease modelsWoori Kim, Mohit Tripathi, Chunhyung Kim, et al.
The Journal of General Physiology|February 6, 2019
Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensorsAmol V Shivange, Philip M Borden, Anand K Muthusamy, et al.
Pediatric Blood & Cancer|April 23, 2014
Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromasBrigitte C Widemann, Dusica Babovic-Vuksanovic, Eva Dombi, et al.
Journal of Neurology|May 16, 2009
Factors that influence adherence with disease-modifying therapy in MSKatherine Treadaway, Gary Cutter, Amber Salter, et al.
Journal of Athletic Training|May 2, 2023
Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus StatementJeffrey B Driban, Heather K Vincent, Thomas H Trojian, et al.
Journal of Athletic Training|May 2, 2023
Evidence Review for Preventing Osteoarthritis After an Anterior Cruciate Ligament Injury: An Osteoarthritis Action Alliance Consensus Statement, Jeffrey B Driban, Heather K Vincent, et al.
Orphanet Journal of Rare Diseases|November 22, 2024
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trialAmel Karaa, Enrico Bertini, Valerio Carelli, et al.
Pageof 9